RecruitingNCT06212635
Hemostasis in Liver Cirrhosis and Hepatocellular Cancer
Novel Biomarkers for Evaluation of Hemostasis and Inflammation in Liver Cirrhosis
Sponsor
Region Stockholm
Enrollment
100 participants
Start Date
Dec 2, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluating hemostasis in decompensated liver cirrhosis with novel hemostatic assays.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at how blood clotting and bleeding processes work differently in people with advanced liver disease (cirrhosis) and liver cancer compared to healthy individuals. Cirrhosis changes how the liver makes clotting proteins, and researchers want to better understand these changes to improve care. Participants will have blood samples taken — no experimental treatment is given.
**You may be eligible if...**
- You are 18 or older
- You have decompensated liver cirrhosis (advanced liver scarring with complications)
- OR you are a healthy volunteer aged 18 or older willing to serve as a comparison
**You may NOT be eligible if...**
- You have had another type of cancer (outside the liver) in the past year
- You have a blood clotting disorder not related to your liver disease
- You have a blood disease such as leukemia, abnormal platelet counts, or hemoglobin disorders
- You have had a previous liver transplant
- You have received a blood transfusion in the last 7 days
- You take blood thinners or antiplatelet medications (other than a preventive low-dose blood thinner)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTT-TAS
Blood test, laboratory assays
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06212635